Summary According to the field cancerisation theory the entire upper aerodigestive tract has been mutagenised, thereby placing the affected individual at risk for the development of one or more cancers. To investigate this concept we studied the respiratory epithelium in lungs bearing cancer, including bronchi, bronchioles and alveoli. After identifying preneoplastic and preinvasive lesions by light microscopy, we determined the DNA content of their nuclei in Feulgen-stained sections using a high-performance digitised image analyser. Archival material from 35 resected cases of non-small-cell lung cancer (NSCLC) was selected, including 16 central tumours (mainly squamous cell carcinomas) and 19 peripheral tumours (mainly adenocarcinomas) and five resected cases of metastatic tumour from extrathoracic primary sites. Of the NSCLCs, 31/35 (89%) were aneuploid, as were 60% of the metastases from extrathoracic sites. Multiple, focal areas of preneoplasia or preinvasive carcinoma were present in the selected cases. The lesions ranged in severity from hyperplasia through metaplasia and dysplasia to carcinoma in situ. Aneuploid preinvasive lesions were not noted in association with the four diploid tumours but were present only when the accompanying NSCLC was aneuploid. With both central and peripheral tumours, aneuploid preneoplastic lesions were more frequent in the peripheral parts of the lung (bronchioles or alveoli) than in the central bronchi. Both the degree and incidence of aneuploidy increased with progressive severity of morphological change. Aneuploidy was not found in preinvasive lesions accompanying the five metastatic cases. Our findings provide strong support for the concept of field cancerisation.
Lung cancer, including small-cell (SCLC) and non-small-cell (NSCLC) lung carcinoma, remains the major cause of cancer death in the world, with a persistent mortality rate approaching 90% (Minna et al., 1989; Parkin et al., 1993) . Current methods for early detection have failed to prolong the median survival time of some 12 months (Anon, 1984; Kubik et al., 1990) . Thus there is a pressing need for improved ways to detect lung cancer early and to assess patient risk. The rapidly emerging capabilities of molecular technology seem especially appropriate in targeting those cellular changes that presage the evolution of neoplasia before the development of invasive cancer. Such studies may provide methods for prevention or modification of the neoplastic process (Lippman et al., 1993) .
Three important concepts dominate our current beliefs about the pathogenesis of lung cancer: (1) Multiple sequential morphological changes characterise lung cancers. To identify groups of phenotypically altered cells in various body tissues possibly targeted by carcinogen, the term preneoplasia is used. By definition, preneoplasia, although believed to possess carcinogenic potential, is not fixed in its destiny to become cancerous. Nevertheless, changes of preneoplasia have been shown to reflect consistently sequential steps in carcinogenesis, and the respiratory epithelium provides an excellent model in which to study such a process. Tumours of the respiratory epithelium may arise in the central compartment (from bronchi) or in the peripheral compartment (from bronchioles or alveoli). Because of ease of accessibility, the best-documented examples of preneoplastic and preinvasive lesions are in the larger bronchi associated with central tumours. They include epithelial hyperplasia, squamous metaplasia, dysplasia of progressive severity and carcinoma in situ (CIS) (Saccomanno et al., 1974; Auerbach et al., 1979 changes may appear in non-metaplastic epithelium of bronchioles and alveoli in association with peripherally arising carcinomas (Nakanishi, 1990; Weng et al., 1990; . However, most preneoplastic lesions do not progress to invasive cancer and some may spontaneously regress (Auerbach et al., 1962a; Frost et al., 1986) . (2) Multiple genetic abnormalities including activation or overexpression of dominantly acting oncogenes and inactivation of recessive growth-regulatory genes (tumoursuppressor genes) are associated with most tumours (Minna, 1993; Gazdar and Carbone, 1994) . Presently there is only a modest amount of knowledge about the sequence of molecular events in lung and their relationship to morphology (Sundaresan et al., 1992; Sugio et al., 1994; Hung et al., 1995 (Slaughter et al., 1954) . He referred to this phenomenon as 'field cancerisation,' a concept that has since been extended by others (Heyne et al., 1992; Sagman et al., 1992) . While Slaughter's observations were originally directed to head and neck cancers, they apply equally well to tumours of the respiratory tract and oesophagus (Carter, 1978; Saccomanno, 1982; McCombe et al., 1989; Heyne et al., 1992; Sagman et al., 1992) . Further evidence of widespread genetic damage and DNA instability is evidenced by the frequent presence of aneuploidy (that is, abnormal nuclear content of DNA) in invasive lung cancers of all histological types (Bunn et al., 1983; Volm et al., 1988) . Aneuploidy may be determined by several techniques such as quantitative flow cytometry, cytospectrophotometry and image analysis (Boone et al., 1992 ). Because precise histological identification is essential for the studies described herein, we used a high-performance image analyser to map the extent and degree of aneuploidy in preneoplastic lesions in both compattments of the respiratory epithelium. Our studies demonstrate that multiple foci of aneuploidy occur at a relatively early stage in the pathogenesis of both central and peripheral tumours and lend credence to the field cancerisation concept.
Materials and methods
Patient selection and data Specimens of cancerous lung were obtained from the surgical pathology files of the Department of Pathology, University of Texas Southwestern Medical Center and affiliated hospitals. They had been fixed in 10% buffered formalin and embedded in paraffin. After examination of more than 100 cases we selected 40 cases representing patients in whom surgical resection had been done for cancer and in whose specimen multiple areas of preneoplasia were present. Thirtyfive patients, ranging in age from 41 to 81 years, had primary lung cancers; five had metastases from extrathoracic primary sites. Twenty-three cancers were from the right lung and 17 from the left. Lobectomy was performed in 27 patients, pneumonectomy in four and wedge resection or lingulectomy in nine. Pathological examination We categorised the 35 primary NSCLCs into two groups: (a) those connected to and apparently arising from a bronchus as central tumours (n = 16) (mostly squamous cell carcinomas) and (b) those not connected to a bronchus and apparently arising from bronchioles or alveoli as peripheral tumours (n = 19) (mostly adenocarcinomas). We included four other malignancies, an atypical carcinoid (central tumour), two large cell carcinomas and an adenosquamous carcinoma (peripheral tumours). The five metastatic neoplasms were renal, laryngeal, breast (one each) and two colorectal carcinomas.
To locate and identify preneoplastic lesions in central and peripheral components of the respiratory tract we examined all available histological material from all cases. After pathological examination we selected suitable tissue blocks (1-3 per case) for further analysis. Tissue blocks were serially sectioned at 5,um to give matched pairs of microslides, one of which was stained with haematoxylin and eosin (H&E) and the other by the Feulgen reaction (Feulgen and Voit, 1924) . By identifying lesions in each pair of microslides, we correlated conventional morphology with ploidy.
Identification ofpreneoplastic lesions Bronchial, bronchiolar and alveolar lining surfaces of the respiratory tract were inspected by brightfield microscopy for the presence and range in severity of the key lesions of preneoplasia -hyperplasia, metaplasia and dysplasia. We included non-invasive carcinoma or carcinoma in situ (CIS) as a preneoplastic lesion although technically it is a preinvasive one. Our criteria for identification of preneoplastic lesions in the different compartments of the respiratory tract were as follows (some of the lesions are illustrated in Figures 1 and 2): Hyperplasia in bronchi is an increase in number of otherwise normally appearing cells normally arranged but in overcrowded multilayered displays of basal or mucous cells. The single cell lining of bronchioles is replaced by basal or Clara cells crowded and piled upon one another. In pulmonary alveoli, hyperplastic type II pneumocytes appear enlarged and occasionally piled up. They may be multinucleated with delicately vacuolated cytoplasm and show small, round nucleoli.
Metaplasia is replacement of the usual respiratory epithelium by squamous epithelium showing a relatively normal maturation process. It is present mainly in bronchi, occasionally in bronchioles.
Dysplasia is the distortion of normal cytological features, usually with disturbed polarity. It is characterised by the presence of enlarged, hyperchromatic and irregularly shaped nuclei. The nuclear cytoplasmic (N/C) ratio in dysplastic cells is consistently increased. While dysplasia in respiratory epithelial cells is often associated with squamous metaplasia, dysplastic changes may be seen in the non-metaplastic respiratory epithelium. In our study the findings of adenomatous hyperplasia/alveolar adenoma, which may be observed in peripheral airspaces, are included in the lesions evaluated as 'dysplasia'. (Miller et al., 1988; Miller, 1990; Shimosato and Miller, 1993) , we describe its features. While it has also been termed bronchioloalveolar adenoma (Miller, 1990) , we use the term alveolar adenoma for this entity. In adenomas, the alveolar lining is replaced by a single layer of cuboidal cells with scant cytoplasm. A mild to moderate degree of nuclear atypism is (Greenberg, 1987) , the distinction between the lepidic tumour growth of adenocarcinoma or adenocarcinoma in situ is obscure (Figure lb) .
We use the term CIS for this growth pattern without further qualification.
Ploidy analysis
The Feulgen reaction, a two-step procedure specific for DNA (Feulgen and Voit, 1924) , was performed as previously described (Carson, 1990) . The Feulgen reaction allows the stoichiometric measurement of DNA (Nasiell and Kato, 1978 Aneuploidy in corresponding preneoplastic lesions was present in 18/31 (58%) of the aneuploid NSCLCs (Table III) . Aneuploidy was absent in preneoplastic lesions associated with near-diploid tumours and with metastatic tumours. Thus only aneuploid tumours displayed aneuploidy in preneoplasia. An example of a typical DNA histogram is illustrated in Figure 3 .
As also shown in Table III , aneuploid preneoplastic lesions were present throughout the central and peripheral compart- Incidence and degree of aneuploidy correlated with tissue lesion As demonstrated in Figure 4 the incidence and degree of aneuploidy increased in correlation with progressive severity of morphological change. In all aneuploid cases the DI values of the tumours were higher than those of their corresponding preneoplastic lesions. Aneuploidy was not found in histologically normal epithelium. A low level of aneuploidy was found in a minority of hyperplastic lesions, but the distinction between hyperplasia and mild dysplasia in Feulgen-stained microslides is difficult. Of 18 alveolar adenomas found in association with primary lung carcinomas, three (17%) were aneuploid (mean DI of 1.4). Two adenomas associated with metastatic cancers were diploid.
Discussion
Understanding the molecular changes in the respiratory epithelium that precede the development of invasive cancers is crucial to the development of rational strategies for therapy and chemoprevention. Therefore, elucidation of the meaning of field cancerisation and its implications represents an important area in carcinogenesis research (Lippman et al., 1993) . In an effort to evaluate the relationship between preneoplastic changes and invasive carcinoma we determined the ploidy of the various preneoplastic changes found throughout the respiratory epithelium of patients with lung cancers.
Multifocal histopathological lesions are present in the respiratory epithelium of patients with lung cancer. A link has been established between smoking and radiation and the appearance and sequential progression of bronchial (central) preneoplastic lesions to invasive lung cancers (Auerbach et al., 1957 (Auerbach et al., , 1962b Saccomanno et al., 1974) . Histologically similar changes have been described even in the lungs of patients without cancer or in association with metastases to the lung from non-pulmonary primary cancers (Bernardi and Delsedime, 1989; Nakayama et al., 1990; Weng et al., 1992; . That moderate to severe squamous bronchial (central) dysplasia may spontaneously regress or never progress to invasive carcinoma has also been reported (Auerbach et al., 1962a; Frost et al., 1986 (Miller, 1990; . Since the malignant potential for many of these histopathological changes is not fully understood, for convenience, we refer to all of them as being preneoplastic.
We compared the frequency and degree of aneuploidy in preneoplastic lesions with their corresponding carcinomas. We found that 31 (89%) of 35 of the primary tumours were aneuploid with a mean DNA index (DI) of 1.8. This finding is in accord with previously published reports (Bunn et al., 1983; Volm et al., 1988) . We observed aneuploidy in one or more preneoplastic lesions in 18 (51%) of 35 cases. However, aneuploidy was only present when the accompanying carcinoma was aneuploid (58% of the aneuploid tumour subset). Although some preneoplastic lesions had a DI greater than 1.5, in every instance, the DI of the tumour was greater than in the corresponding preneoplastic lesion. Three (60%) of five metastatic tumours were aneuploid, but none of the relatively mild preneoplastic lesions associated with metastatic tumours was aneuploid.
The degree and incidence of aneuploidy increased with progressive severity of histopathological change. Aneuploidy was occasionally observed in hyperplasia, usually appeared at the stage of dysplasia and then escalated along the postulated multistage pathway into invasive cancer. Although a low level of aneuploidy was detected in 20% of hyperplastic lesions, a distinction between hyperplasia and mild dysplasia in Feulgen-stained microslides is difficult. We believe that aneuploidy appears at the hyperplasia-dysplasia interface.
Our Kogan et al., 1991; . our report documents that it is extensive, especially in the peripheral parts of the lung. These findings provide support for the concept that the peripheral lesions are truly preneoplastic in nature.
Because aneuploidy can predispose to genomic instability (Loeb, 1991) , it may be one of the predisposing causes of the multiple genetic abnormalities frequently present in invasive cancers. Reports of cytogenetic and other changes in preneoplastic bronchial lesions and even in 'normal' bronchial epithelium provide further evidence for this concept (Sozzi et al., 1991 (Sozzi et al., . 1992 . Recently, we have described deletions of the short arm of chromosomes 3 and 9 in hyperplastic lesions throughout the respiratory tree (Hung et al., 1995) .
These chromosomal regions are the sites of known or putative recessive oncogenes important for the development of lung cancers of all histological types (Minna, 1993; Gazdar and Carbone. 1994 (Miller, 1990; .
Aneuploidy is present in multiple preneoplastic foci located throughout the respiratory epithelium from the stage of dysplasia onwards and increases in incidence and degree with progressive histopathological changes. These findings provide considerable support for the field cancerisation theory. Thus, aneuploidy may be a useful intermediate marker for assessing risk and monitoring the efficacy of chemoprevention trials.
